SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-027570
Filing Date
2021-05-13
Accepted
2021-05-13 16:19:40
Documents
67
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q snse-10q_20210331.htm 10-Q 1280645
2 EX-31.1 snse-ex311_10.htm EX-31.1 19284
3 EX-31.2 snse-ex312_9.htm EX-31.2 19595
4 EX-32.1 snse-ex321_8.htm EX-32.1 9549
  Complete submission text file 0001564590-21-027570.txt   4902500

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT snse-20210331.xml EX-101.INS 835238
6 XBRL TAXONOMY EXTENSION SCHEMA snse-20210331.xsd EX-101.SCH 49783
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snse-20210331_cal.xml EX-101.CAL 38632
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snse-20210331_def.xml EX-101.DEF 155217
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE snse-20210331_lab.xml EX-101.LAB 372260
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snse-20210331_pre.xml EX-101.PRE 282084
Mailing Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879
Business Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879 (240) 243-8000
Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39980 | Film No.: 21919931
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences